Bioprinted tissues accelerate healing through natural integration, reducing infection, scarring, and recovery times compared to traditional implants or synthetic substitutes.

Bioprinting could extend the average lifespan by 5-10 years, potentially improving treatment effectiveness for cancer, heart disease, and addressing organ shortages, according to a biotech expert.

The personalized medicine industry is growing rapidly, driven by increasing demand for novel drug discovery and rising disease incidence.

Bioprinting technology can revolutionize research and drug development for neglected diseases like malaria, Chagas, and river blindness by creating precise 3D tissue models for detailed study.